RenBio
RenBio is a startup headquartered in Long Island City, United States, founded in 2020. It has raised at least $5.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
RenBio has raised at least $5.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
RenBio sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in Long Island City
Related
- Innovation profile of Long Island City
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does RenBio do?
RenBio is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has RenBio raised?
At least $5.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is RenBio based?
RenBio is headquartered in Long Island City, United States.
When was RenBio founded?
RenBio was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.